<DOC>
	<DOCNO>NCT00236613</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness topiramate ( 64mg , 96mg , 192mg , 384mg daily ) placebo treatment obesity .</brief_summary>
	<brief_title>A Study Efficacy Safety Topiramate Treatment Patients With Obesity</brief_title>
	<detailed_description>Topiramate approve treatment obesity . This randomized , double-blind , placebo-controlled , multicenter study assess safety effectiveness topiramate treatment obese patient . Patients receive 24 week treatment topiramate placebo , follow 2 week taper safety follow-up . Effectiveness determine change baseline week 24 body weight , body mass index ( BMI ) , anthropometric measurement ( waist circumference , hip circumference , waist/hip ration ) , fast lipid profile , fast plasma glucose , HbA1c ( show average blood sugar level month ) , fast uric acid , fast insulin , blood pressure . Safety evaluation ( incidence adverse event , physical examination , 12 lead ECGs , vital sign , Computerized Neuropsychological Test Battery ) perform throughout study . The study hypothesis topiramate effective achieve maintain weight reduction obese patient well tolerate . The patient randomize receive either topiramate ( 64 , 96 , 192 , 384 mg daily ) placebo daily mouth 24 week .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Body Mass Index ( BMI ) &gt; =30 &lt; 50 BMI &gt; = 27 &lt; 50 patient control hypertension abnormal blood lipid Stable weight Female patient must postmenopausal least 1 year , surgically incapable childbearing , practice abstinence , practice acceptable method contraception ( require negative pregnancy test ) Known contraindication , hypersensitivity topiramate Exposure experimental drug device within last 30 day A diagnosis diabetes History evidence clinically significant liver disease , cardiovascular disease , uncontrolled hypertension high thyroid level History obesity know cause History family history kidney stone History weight loss surgery History malignancy within last 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Body Mass Index</keyword>
</DOC>